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It is now well established that antithxombin can 
act as an inhibitor of all the serine proteases of the 
intrinsic coagulation system [l-7]. The inhibition, 
which: is accelerated by heparin , involves the formation 
of an inactive, extremely stable (possibly covatent 
[S]), equimolar complex between the inhibitor and 
the serine protease. In spite of the fact that the 
eq~imo~~ty of the &active compIex has been con- 
v~~~~y demon~~ted f2] , studies of the anti- 
~~arnb~-~rornb~ reaction have shown that total 
ambition of the protease is not achieved until a 
molar excess of antithrombin is present [9], It has 
been postulated that the reason for this is the pro- 
teolytic inactivation of free inhibitor by the enzyme. 
Evidence for a proteolytic modification of anti- 
thrombin by thrombin can be found [2,1 O] , but no 
detailed studies of the products of this reaction have 
been made. This report deals with the ~~~Iirnin~ 
~ha~~c~e~ation and with various conditions for the 
formation of such a proteoly~~~y modified form of 
~~t~ro~~b~, which is rapidly formed in consider- 
able amounts in the presence of ~r~~bIn, This form 
has lost the ability to inhibit thrombin and has reduced 
affinity for heparin. 
2. Mate&ls and methods 
Bovine ~tithromb~n~ human a~~~~r~rnb~ and 
heparin, coupled to Sepharose 4B, were prepared by 
methods detailed in ]11,12]. A preparation of bovine 
~-~rombin that was a generous gift from Dr Craig 
Jackson, Wa~~~~n University, St Louis, MO, was 
used in most experiments. However, comparable 
results were obtained with commercial thrombin 
purified on heparin-Sepharose [I 31. 
Disc gel electrophoresis orgradient-pore elec-tro- 
phoresis in dilute buffer, and gel electrophoresis in 
the presence of sodium dodecyf sulfate followed 
methods detailed in f 11,141. Gel electrophoresis at 
pH 33 in 8 M urea on 7 =~~~~~ stepgradient poly- 
acrylamide gels was performed essentially as in [I S] . 
Spe~trop~~tometrIc assays for ~#ithrombi~ and 
~rornb~ ac~vities essentially followed the rne~lods 
in [9,16]. 
Protein concentrations were measured spectro- 
photometrically. A pre-determined specific absorp- 
tion coefficient (4 !$,) of 6.7 was employed for 
bovine antithrombin [ 141, while a specific absorp- 
tion coefficient of 17.5 was measured for bovine 
thrombin fl7]. 
The p~~~t~v~ rornb~-rno~~ed bovine anti- 
thrombin was prepared from native bovine antiV 
thrombin by the following procedure. A suspension 
of heparin-Sepharose, quilibrated in 0.05 M 
Tris . Cl + Q,2O M NaCI (pH 7.5) was saturated with 
bovine antith~ombin, and the excess protein removed 
by washing. About 3.5 mg protein was found to b&d 
per ml settled gel. Bovine ~rornbjn~ dissolved in the 
equ~ibrat~~~ buffer, was added to the gel suspension 
in an amount representing half the number of moles 
of an~~romb~ bound to the gel. The gei was washed 
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with the above buffer, and all protein which was 
released from the he~a~n~~harose atthis ionic 
strength was combined. At this stage, > 80% of the 
protein in the preparation was the putative thrombin- 
modified antithrombin as judged by SDS-gel electro- 
phoresis. The preparation was further purified by sub- 
sequent gel chromatography on Sephacryl S-200 
followed by rechromatography on heparin-Sepharose. 
In the latter procedure, elution was effected by a 
linear gradient from 0.02 M Tris . Cl (pH 7.4) to OS M 
NaCl in the same buffer. The final yield of putative 
~rombin-mooed ~tithromb~ by this procedure 
was -2O!%, while SDS-gel electrophoresis suggested 
that its actual production may be up to 40% of the 
native antithrombin originally bound to the heparin- 
Sepharose . 
In dilute buffer, the isolated protein &ted from a 
Sephacryl S-200 column at the same position as native 
bovine antithrombin and could not be differentiated 
from the native protein either by disc-gel electro- 
phoresis, gradient-gel ectrophoresis orimmuno- 
electrophoresis. A reaction of immunological identity 
with native bovine antithrombin was obtained in 
immu~o~ffu~on analyses. The protein exhibited no 
thrombin activity,and no ~tithromb~ activity either 
in the presence or absence of heparin, It eluted from 
hepar~-Sepharose at -0.25 ionic stren~hdu~ng gradient 
elution. Thus, the protein’s binding of heparin is much 
weaker than that of native bovine antithrombin, which 
elutes from heparin-Sepharose at -0,8 ionic strength 
[ 111. Together these data suggest that the isolated 
protein is bovine antithrombin which has been modi- 
fied in some manner in the presence of thrombin. 
Figure I presents acomparison of the electro- 
phoretic behaviours under denaturing conditions of 
bovine an~thromb~ and the putative thrombin- 
modified antithromb~= In SDS, a difference in electro- 
phoretic mobility between the two could be detected 
only under reducing conditions (gels I-3). Efectro- 
phoresis of the reduced proteins on stepgradient 
polyacrylamide gels in 8 M urea (pH 3 3) visualized 
a small polypeptide, which was released upon reduc- 
tion only from the putative thrombinmodified anti- 
thrombin (gels 4-6). It was later found that the 
smaller peptide also could be observed as a lightly 
staining, diffuse band ahead of the marker dye on 
standard SDS-gels. Comparison of the mobility of 
the smaller peptide in 8 M urea (pH 3.3) with the 
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F&l. A ccrnpar~son of She ~ec~ro~h~re~~~ behaviour in 
denaturing solvents of ~~~rornb~ and ~rorn~~~~ed 
antithrombin. Gel 1, a mixture of bovine ~f~thrombi~ and 
thmmb~n~od~ed anti~romb~, unreduced in SDS. Gel 2, 
thrombin-rn~~~d antithrombin, reduced in SDS. Gel 3, 
a mixture of bovine antithrombin and thrombiu-modified 
antithrombin, reduced in SDS. Bovine antithrombm is marked 
with an arrow. Gel 4, bovine antithrombin, unreduced in 
8 M urea (pII 3.3). Gel 5, thrombin-modified antithrombin, 
unreduced in 8 M urea (pH 3.3). Gel 6, thrombiu-modified 
antithrombiu, reduced and carbaminomethylated, in 8 M 
urea (pH 3.3). Gel 7, bovine antithrombm, reduced and 
carbaminomethyiated, in 8 M urea fpH 3.3). The position 
of the tracking dye is indicated by a prick in the gel with 
India ink. 
mobility of the thrombin Achain suggested that the 
former has mol. wt 5000. The larger polypeptide of 
modified antithrombin was estimated to have mol. wt 
50 000 by comparison of its mobility in SDS-gel 
electrophoresis with those of standard polypeptides. 
Thrombin was incubated with native antithrombm 
under various experimental conditions in order to 
verify that the modified form of antithrombin did 
not result only as a consequence of the conditions 
under which it was prepared but thai it arises naturally 
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in the encounter of thrombin and antithrombin in 
solution. The products of these incubations were 
monitored for the presence of the larger polypeptide 
- 
Fig.2. The production of thrombm-modified antithrombin 
under different sets of experimental conditions. The principal 
electrophoretic omponents are antithrombin-thrombin 
complex (ATT), antithrombin (AT), thrombin-modified 
antithrombin (ATM), and the B-chain of bovine or-thrombin 
(T). Absolute mobilities differ from gel to gel; therefore 
~tithrom~m is marked with an arrow. Gel 1, equimolar 
amounts of bovine ~tithromb~ and bovine thrombin, 
incubated for 30 s at 25°C (pH 7.4). Gel 2, as in gel 1 except 
incubation was for 120 min. Gel 3, a 4-fold molar excess of 
bovine antithrombin over bovine thrombin incubated for 
30 s at 25’C (pH 7.4). (Because of the large relative quantity 
of native antithrombin, the small region of separation between 
the modified and native antithrombm on this gel is not 
easily visible on the photograph.) Gel 4, equimolar amounts 
of bovine antithrombin and bovine thrombin in the presence 
of heparin (molar ratio of 0.25 relative to antithrombm) 
incubated 10 s at 25“C (pH 7.4). Gel 5, equimolar amounts 
of human antithrombin and bovine thrombin incubated for 
1 min at 37°C (pH 7.4). Gel 6, equimolar amounts of bovine 
antithromb~ and bovine thrombin in the presence of 1 M 
benzami~mium chloride incubated 5 h at 25OC (pH 7 A). 
Samples were heated 5 min in a boiling water bath in the 
presence of a S-fold weight excess of SDS and 10% P-mercapto- 
ethanol (pH 7.4). 15 pg protein was applied to each gel. 
chain of ~rornb~-modi~ed antithrombin by SDS-gel 
electrophoresis under reducing conditions. The results 
are summarily illustrated in fig.2. Within the time 
that the first sampling could be made (about 10 s), 
both the thrombin-antithrombin complex and the 
large polypeptide of thrombin-modified antithrombin 
were observed. The quantities of these two products 
increased until the thrombin or antithrombin was 
depleted. Beyond this point, the quantity of thrombin- 
modified ant~thromb~ appeared to remain constant 
(cf. gels 12). Within the limits ~vestigated, the 
appearance of the modified ~tithromb~ was 
independent of the molar ratio of antithrombin to 
thrombin used (gels 13). The rate of production of 
modified antithrombin increased in the presence of 
heparin in a manner qualitatively similar to the rate 
of formation of the antithrombin-thrombin complex 
(gel 4). A product similar to that produced from 
bovine antithrombin was also observed when human 
antithrombin was incubated with bovine thrombin 
(gel 5). l?inally, the conclusion that this modified 
an~thromb~ isa product of thromb~ action is 
supported by the observations that none of it was 
formed when antithrombin was incubated with 
thrombin which had been inactivated with phenyl- 
methylsulfonylfluoride, orwhen thrombin and anti- 
thrombin were incubated in the presence of high 
concentrations of benzamidinium chloride (gel 6). 
4. Discusion 
These results establish that considerable amounts 
of an inactive species of antithrombin arise in the 
presence of thrombin as a result of the proteolytic 
action of the enzyme. The inactivation appears to 
involve the scission of one or at most a few adjacent 
peptide bonds, located 30-60 residues from one of 
the ends of the antithrombin polypeptide chain. The 
narrow substrate specificity of thrombin suggests hat, 
in fact, the cleavage may take place at one peptide 
bond only. The two polypeptides which result remain 
covalently attached through a disulfide linkage and 
can be separated only after reduction under denaturing 
conditions. The localized chain hydrolysis of anti- 
~rornb~ not only renders it incapable of thrombin 
inactivation but also virtually eliminates its heparin 
binding capacity. This marked alteration of the func- 
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tion of the protein indicates that a conformational 
change may follow the proteolytic event. The inactiva- 
tion of antithrombin by thrombin concurrent with 
the formation of the complex between the two pro- 
teins offers a quite feasible reason for the finding that 
greater-thanequimolar quantities of antithrombin are 
required to completely neutralize thrombm [9]. 
The thrombin-modified antithrombin was shown 
to arise under a broad range of in vitro conditions, 
which suggests that its formation might also occur 
in vivo. In this regard, it is worth noting that an 
inactive form of antithrombin was demonstrated [lo] 
in serum produced by the clotting of plasma with 
exogenous thrombin. The modified antithrombin we 
have isolated may be identical to this form, although 
the paucity of the data available renders a comparison 
difficult. Of further interest is that a perusal of the 
literature which deals with the inactivation by anti- 
thrombin of various coagulation serine proteases [2-61 
suggests that formation of modified antithrombin 
may not be restricted to the thrombin system. 
We do not know at this time what the significance 
may be of this seemingly ‘dead end’ product in the 
interaction between thrombin and antithrombin. 
However, the fact that a protease inhibitor is easily 
inactivated by what appears to be a single bond 
hydrolysis catalyzed by its target enzyme is rather 
puzzling. Comprehensive physical and chemical studies 
are currently in progress in an attempt to answer this 
question. 
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